company background image
002755 logo

Beijing Aosaikang Pharmaceutical XSEC:002755 Stock Report

Last Price

CN¥13.23

Market Cap

CN¥12.3b

7D

4.6%

1Y

31.9%

Updated

25 Nov, 2024

Data

Company Financials +

Beijing Aosaikang Pharmaceutical Co., Ltd.

XSEC:002755 Stock Report

Market Cap: CN¥12.3b

Beijing Aosaikang Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Beijing Aosaikang Pharmaceutical
Historical stock prices
Current Share PriceCN¥13.23
52 Week HighCN¥15.10
52 Week LowCN¥6.50
Beta0.34
11 Month Change-2.86%
3 Month Change17.39%
1 Year Change31.90%
33 Year Change15.55%
5 Year Change-12.90%
Change since IPO14.64%

Recent News & Updates

Recent updates

Shareholder Returns

002755CN PharmaceuticalsCN Market
7D4.6%0.3%-0.6%
1Y31.9%-7.9%3.2%

Return vs Industry: 002755 exceeded the CN Pharmaceuticals industry which returned -9.4% over the past year.

Return vs Market: 002755 exceeded the CN Market which returned 2.8% over the past year.

Price Volatility

Is 002755's price volatile compared to industry and market?
002755 volatility
002755 Average Weekly Movement7.4%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.4%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 002755 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 002755's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003979Jingfei Mawww.ask-pharm.com

Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in digestive, oncology, antibiotic, and other areas.

Beijing Aosaikang Pharmaceutical Co., Ltd. Fundamentals Summary

How do Beijing Aosaikang Pharmaceutical's earnings and revenue compare to its market cap?
002755 fundamental statistics
Market capCN¥12.28b
Earnings (TTM)CN¥163.14m
Revenue (TTM)CN¥1.71b

75.3x

P/E Ratio

7.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002755 income statement (TTM)
RevenueCN¥1.71b
Cost of RevenueCN¥324.09m
Gross ProfitCN¥1.38b
Other ExpensesCN¥1.22b
EarningsCN¥163.14m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.18
Gross Margin81.03%
Net Profit Margin9.55%
Debt/Equity Ratio2.9%

How did 002755 perform over the long term?

See historical performance and comparison